Could remifentanil reduce duration of mechanical ventilation in comparison with other opioids for mechanically ventilated patients? A systematic review and meta-analysis.
Yi-Bing ZhuYinhua WangBin DuXiuming XiPublished in: Critical care (London, England) (2017)
Remifentanil seems to be associated with reductions in the duration of mechanical ventilation, time to extubation after cessation of sedation, and ICU-LOS. No significant differences were identified between remifentanil and other opioids in terms of hospital-LOS, costs, mortality or agitation.
Keyphrases
- mechanical ventilation
- acute respiratory distress syndrome
- intensive care unit
- respiratory failure
- end stage renal disease
- chronic pain
- extracorporeal membrane oxygenation
- ejection fraction
- pain management
- newly diagnosed
- chronic kidney disease
- healthcare
- peritoneal dialysis
- emergency department
- risk factors
- cardiovascular events
- patient reported outcomes
- type diabetes
- adverse drug
- cardiac surgery
- acute kidney injury
- acute care
- electronic health record